Sentinels deepens UK presence with new CCO appointment
RegTech firm Sentinels has appointed Adrian Jenkins to the role of chief commercial officer.
How FATF’s ultimate beneficial ownership changes affect your risk-based approach
Earlier this year, the Financial Action Task Force adopted amendments to Recommendation 24 – one of its 40 recommendations that govern global AML policy – making changes to Ultimate Beneficial Ownership. How will this impact your company?
Why transaction monitoring for crypto firms is imperative
As cryptocurrency continues to become a staple in mainstream financial life, the voices around its regulation are getting louder.
kevin. appoints Sentinels to handle transaction monitoring compliance
RegTech firm Sentinels has been appointed by payments FinTech kevin. to handle transaction monitoring compliance for the company.
How to bolster transaction monitoring for FinTechs
There is no doubt FinTech is a booming industry. The sector, according to Statista, is expected to grow at an average rate of 12% to reach a value of €188bn by 2024. This makes transaction monitoring a hot-button issue going forward.
Could 2022 be the year of the CBDC?
With the rise of cryptocurrencies showing no signs of slowing down, the growth of central bank digital currencies (CBDC) appears to be another trend on the ascendancy. Will 2022 prove to be a red-letter year for CBDC adoption?
Sentinels selected by Dutch neobank Brand New Day
Sentinels, a transaction monitoring and client risk management platform, has been selected by Netherlands-based neobank Brand New Day to scale its anti-money laundering (AML) controls.
Liberty City Ventures backs Solidus Labs in $45m round
Solidus Labs, a provider of crypto-native risk monitoring and market surveillance, has raised $45m in Series B funding led by Liberty City Ventures.
Westpac hit with $40m fine for charging fees to the deceased
Australian bank Westpac has been fined $40m after it was founded to have charged fees to over 11,800 deceased individuals.
How do EU and UK AML regulations differ post-Brexit?
Prior to the UK leaving the EU at the beginning of 2021, the UK had mostly regulatory alignment with the Union. Since Brexit, the divisions have emerged. How has this impacted AML regulatory alignment?













